Clinical Trial Update: Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab [NA]

View source ↗

Summary

A clinical trial evaluating a cardiac rehabilitation program to prevent cancer therapy–related cardiotoxicity in breast cancer patients treated with anthracycli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez | Conditions: Cancer Therapy-Related Cardiac Dysfunction | NA | Status: NOT_YET_RECRUITING